Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer
VANCOUVER, British Columbia, November 7, 2023 – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Canadian psychedelics drug research and formulation company, is delighted to announce the appointment of Dr. Preston A. Chase as the Company’s Chief
November 7, 2023
